https://www.marketscreener.com/quote/stock/VERTEX-PHARMACEUTICALS-IN-11321/news/Vertex-Pharmaceuticals-Phase-3-Studies-of-the-Tezacaftor-Ivacaftor-Combination-Treatment-in-People-25433227/?utm_source=telegram&utm_medium=social&utm_campaign=share